Lisa Caporelli
Conference Call Host
Replay available
Arbutus Biopharma Corporation (ABUS) Q2 2023 Earnings Call
Arbutus Biopharma Corporation (NASDAQ: ABUS) Q2 2023 earnings conference call, held 2023-08-03. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Bill Collier
President and Chief Executive Officer
Dr. Karen Sims
Chief Medical Officer
David Hastings
Chief Financial Officer
Dennis Deng
Analyst, Jefferies
Roy Buchanan
Analyst, JMP
Dr. Mike Sophia
Chief Scientific Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Arbutus Biopharma Corporation.
Replay transcript excerpt
WEBVTT 00:00:00.049 -- 00:00:05.493 Good day, and thank you for standing by. Welcome to the Arbutus Biopharma Q2 00:00:05.493 -- 00:00:09.817 conference call. At this time, all participants are in a listen-only mode. 00:00:09.817 -- 00:00:13.399 After the speaker's presentation, there will be a question-and-answer session. 00:00:13.399 -- 00:00:17.502 To ask a question during the session, you will need to press star 11 on your telephone. 00:00:17.502 -- 00:00:21.285 You will then hear an automated message advising that your hand is raised. 00:00:21.285 -- 00:00:24.168 To withdraw your question, please press star 11 again. 00:00:24.168 -- 00:00:27.330 Please be advised that today's conference is being recorded. 00:00:27.330 -- 00:00:31.644 I would now like to hand the conference over to your speaker today, Lisa Caporelli, please 00:00:31.644 -- 00:00:32.585 go ahead. 00:00:32.585 -- 00:00:36.859 Thanks, Jada. Good morning, everyone, and thank you for joining Arbutus' second quarter 00:00:36.859 -- 00:00:41.032 2023 financial results and corporate update call. 00:00:41.032 -- 00:00:46.237 Joining me today from the Arbutus executive team are Bill Collier, President and Chief 00:00:46.237 -- 00:00:51.341 Executive Officer, David Hastings, Chief Financial Officer, Dr. 00:00:51.341 -- 00:00:54.704 Mike Sophia, Chief Scientific Officer, and Dr. 00:00:54.704 -- 00:00:59.738 Karen Sims, Chief Medical Officer. Bill will begin with a corporate 00:00:59.738 -- 00:01:05.801 update, followed by Dr. Sims, who will review recent data shared at a medical congress. 00:01:05.801 -- 00:01:10.724 Dave Hastings will then provide a review of the company's second quarter 2023 financial 00:01:10.724 -- 00:01:15.806 results. After our prepared remarks, we will open the call for Q&A. 00:01:15....